Literature DB >> 31919282

Loss of TSC complex enhances gluconeogenesis via upregulation of Dlk1-Dio3 locus miRNAs.

Dritan Liko1, Andrzej Rzepiela2, Vanja Vukojevic3,4,5, Mihaela Zavolan2, Michael N Hall6.   

Abstract

Loss of the tumor suppressor tuberous sclerosis complex 1 (Tsc1) in the liver promotes gluconeogenesis and glucose intolerance. We asked whether this could be attributed to aberrant expression of small RNAs. We performed small-RNA sequencing on liver of Tsc1-knockout mice, and found that miRNAs of the delta-like homolog 1 (Dlk1)-deiodinase iodothyronine type III (Dio3) locus are up-regulated in an mTORC1-dependent manner. Sustained mTORC1 signaling during development prevented CpG methylation and silencing of the Dlk1-Dio3 locus, thereby increasing miRNA transcription. Deletion of miRNAs encoded by the Dlk1-Dio3 locus reduced gluconeogenesis, glucose intolerance, and fasting blood glucose levels. Thus, miRNAs contribute to the metabolic effects observed upon loss of TSC1 and hyperactivation of mTORC1 in the liver. Furthermore, we show that miRNA is a downstream effector of hyperactive mTORC1 signaling.

Entities:  

Keywords:  CpG methylation; Dlk1-Dio3; glucose metabolism; mTOR; miRNA

Mesh:

Substances:

Year:  2020        PMID: 31919282      PMCID: PMC6983401          DOI: 10.1073/pnas.1918931117

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  67 in total

1.  Two TOR complexes, only one of which is rapamycin sensitive, have distinct roles in cell growth control.

Authors:  Robbie Loewith; Estela Jacinto; Stephan Wullschleger; Anja Lorberg; José L Crespo; Débora Bonenfant; Wolfgang Oppliger; Paul Jenoe; Michael N Hall
Journal:  Mol Cell       Date:  2002-09       Impact factor: 17.970

2.  ICR noncoding RNA expression controls imprinting and DNA replication at the Dlk1-Dio3 domain.

Authors:  Satya K Kota; David Llères; Tristan Bouschet; Ryutaro Hirasawa; Alice Marchand; Christina Begon-Pescia; Ildem Sanli; Philippe Arnaud; Laurent Journot; Michael Girardot; Robert Feil
Journal:  Dev Cell       Date:  2014-09-25       Impact factor: 12.270

3.  TSC2 regulates microRNA biogenesis via mTORC1 and GSK3β.

Authors:  Barbara Ogórek; Hilaire C Lam; Damir Khabibullin; Heng-Jia Liu; Julie Nijmeh; Robinson Triboulet; David J Kwiatkowski; Richard I Gregory; Elizabeth P Henske
Journal:  Hum Mol Genet       Date:  2018-05-01       Impact factor: 6.150

4.  The noncoding RNA IPW regulates the imprinted DLK1-DIO3 locus in an induced pluripotent stem cell model of Prader-Willi syndrome.

Authors:  Yonatan Stelzer; Ido Sagi; Ofra Yanuka; Rachel Eiges; Nissim Benvenisty
Journal:  Nat Genet       Date:  2014-05-11       Impact factor: 38.330

Review 5.  DLK1-DIO3 imprinted cluster in induced pluripotency: landscape in the mist.

Authors:  Leonidas Benetatos; George Vartholomatos; Eleftheria Hatzimichael
Journal:  Cell Mol Life Sci       Date:  2014-08-07       Impact factor: 9.261

6.  The IG-DMR and the MEG3-DMR at human chromosome 14q32.2: hierarchical interaction and distinct functional properties as imprinting control centers.

Authors:  Masayo Kagami; Maureen J O'Sullivan; Andrew J Green; Yoshiyuki Watabe; Osamu Arisaka; Nobuhide Masawa; Kentarou Matsuoka; Maki Fukami; Keiko Matsubara; Fumiko Kato; Anne C Ferguson-Smith; Tsutomu Ogata
Journal:  PLoS Genet       Date:  2010-06-17       Impact factor: 5.917

7.  Meg3 Non-coding RNA Expression Controls Imprinting by Preventing Transcriptional Upregulation in cis.

Authors:  Ildem Sanli; Sébastien Lalevée; Marco Cammisa; Aurélien Perrin; Florence Rage; David Llères; Andrea Riccio; Edouard Bertrand; Robert Feil
Journal:  Cell Rep       Date:  2018-04-10       Impact factor: 9.423

8.  Analysis of DNA methylation acquisition at the imprinted Dlk1 locus reveals asymmetry at CpG dyads.

Authors:  Alyssa Gagne; Abigail Hochman; Mahvish Qureshi; Celia Tong; Jessica Arbon; Kayla McDaniel; Tamara L Davis
Journal:  Epigenetics Chromatin       Date:  2014-05-29       Impact factor: 4.954

9.  Livers with constitutive mTORC1 activity resist steatosis independent of feedback suppression of Akt.

Authors:  Heidi L Kenerson; Savitha Subramanian; Rebecca McIntyre; Machiko Kazami; Raymond S Yeung
Journal:  PLoS One       Date:  2015-02-03       Impact factor: 3.240

10.  Metformin reduces liver glucose production by inhibition of fructose-1-6-bisphosphatase.

Authors:  Roger W Hunter; Curtis C Hughey; Louise Lantier; Elias I Sundelin; Mark Peggie; Elton Zeqiraj; Frank Sicheri; Niels Jessen; David H Wasserman; Kei Sakamoto
Journal:  Nat Med       Date:  2018-08-27       Impact factor: 53.440

View more
  3 in total

Review 1.  Regulation and metabolic functions of mTORC1 and mTORC2.

Authors:  Angelia Szwed; Eugene Kim; Estela Jacinto
Journal:  Physiol Rev       Date:  2021-02-18       Impact factor: 46.500

Review 2.  Small biomarkers with massive impacts: PI3K/AKT/mTOR signalling and microRNA crosstalk regulate nasopharyngeal carcinoma.

Authors:  Hai-Long Li; Nian-Hua Deng; Xiu-Sheng He; Yue-Hua Li
Journal:  Biomark Res       Date:  2022-07-26

Review 3.  The mTOR-Autophagy Axis and the Control of Metabolism.

Authors:  Nerea Deleyto-Seldas; Alejo Efeyan
Journal:  Front Cell Dev Biol       Date:  2021-07-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.